Risk factors for fatal outcome from rocky mountain spotted fever in a highly endemic area - Arizona, 2002-2011

Clinical Infectious Diseases

Volumn 60, Issue 11, 2015, Pages 1659-1666

  Regan, Joanna J ^a   Traeger, Marc S ^b   Humpherys, Dwight ^b   Mahoney, Dianna L ^b   Martinez, Michelle ^b   Emerson, Ginny L ^c   Tack, Danielle M ^d   Geissler, Aimee ^e   Yasmin, Seema ^d   Lawson, Regina ^f   Williams, Velda ^g   Hamilton, Charlene ^g   Levy, Craig ^h   Komatsu, Ken ^h   Yost, David A ^b   McQuiston, Jennifer H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INDIAN HEALTH SERVICE   (United States)

^c Poxvirus and Rabies Branch Division of High Consequence Pathogens and Pathogenicity NCEZID   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f NORTH CAROLINA STATE UNIVERSITY   (United States)

^g U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^h Bureau of Epidemiology and Disease Control   (United States)

Author keywords

American Indians; fatalities; Rhipicephalus sanguineus; Rocky Mountain spotted fever; tick borne

Indexed keywords

AMINOTRANSFERASE; AMOXICILLIN; AZITHROMYCIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; SULTAMICILLIN; VANCOMYCIN;

ABNORMAL LABORATORY RESULT; ADULT; ADVERSE OUTCOME; ALCOHOLISM; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; FATALITY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATOMEGALY; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PERIORBITAL EDEMA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RASH; RISK FACTOR; ROCKY MOUNTAIN SPOTTED FEVER; SPLENOMEGALY; THERAPY DELAY; THROMBOCYTOPENIA; TICK BITE; TIME TO TREATMENT; UNITED STATES; ANIMAL; ENDEMIC DISEASE; PATHOLOGY;

ANIMALS; ENDEMIC DISEASES; FEMALE; HUMANS; MALE; ROCKY MOUNTAIN SPOTTED FEVER;

EID: 84928826280     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ116     Document Type: Article

References (27)

1. Ormsbee RA. A review: "Studies in Pyroplasmosis hominis ('spotted fever' or 'tick fever' of the Rocky Mountains)" by Louis B. Wilson and William M. Chowning, published in the Journal of Infectious Diseases 1:31-57, 1904. Rev Infect Dis 1979; 1:559-62.
2. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55(RR-4):1-27.
3. Pickering LK, Kimberlin DW, Long SS, Baker CJ. Red Book 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2012.
4. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184:1437-44.
5. Hattwick MA, Retailliau H, O'Brien RJ, Slutzker M, Fontaine RE, Hanson B. Fatal Rocky Mountain spotted fever. JAMA 1978; 240:1499-503.
6. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20:1118-21.
7. Westerman EL. Rocky Mountain spotless fever: a dilemma for the clinician. Arch Intern Med 1982; 142:1106-7.
8. Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 2005; 353:587-94.
9. Eremeeva ME, Bosserman E, Zambrano M, Demma L, Dasch GA. Molecular typing of novel Rickettsia rickettsii isolates from Arizona. Ann N Y Acad Sci 2006; 1078:573-7.
10. Eremeeva ME, Dasch GA. Closing the gaps between genotype and phenotype in Rickettsia rickettsii. Ann N Y Acad Sci 2009; 1166:12-26.
11. Maricopa County Department of Public Health. Rocky Mountain spotted fever fact sheet. Available at: http://www.maricopa.gov/publichealth/ Services/EPI/Diseases/rmsf/. Accessed 24 February 2015.
12. Nicholson WL, Paddock CD, Demma L, et al. Rocky Mountain spotted fever in Arizona: documentation of heavy environmental infestations of Rhipicephalus sanguineus at an endemic site. Ann N Y Acad Sci 2006; 1078:338-41.
13. Traeger MS, Regan JJ, Humpherys D, et al. Rocky Mountain spotted fever characterization and comparison to similar illnesses in a highly endemic area-Arizona, 2002-2011. Clin Infect Dis 2015; 60:1650-8.
14. Arizona Department of Health Services. Rocky Mountain spotted fever (RMSF). Arizona statistics. Available at: http://www.azdhs.gov/phs/oids/ vector/rmsf/stats.htm. Accessed 21 March 2013.
15. Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky Mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg 2010; 83:174-82.
16. Dean AG, Coulombier D, Brendel KA, et al. Epi Info, version 3.5.3: a word processing, database, and statistic program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 2010.
17. Childs JE, Paddock CD. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 2002; 66:450-7.
18. Dahlgren FS, Holman RC, Paddock CD, Callinan LS, McQuiston JH. B Rocky Mountain spotted fever in the United States, 1999-2007. Am J Trop Med Hyg 2012; 86:713-9.
19. Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995; 52:405-13.
20. Sousa R, Franca A, Doria Nobrega S, et al. Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J Infect Dis 2008; 198:576-85.
21. Zhang P, Bagby GJ, Happel KI, Raasch CE, Nelson S. Alcohol abuse, immunosuppression, and pulmonary infection. Curr Drug Abuse Rev 2008; 1:56-67.
22. Davis AE Jr, Bradford WD. Abdominal pain resembling acute appendicitis in Rocky Mountain spotted fever. JAMA 1982; 247:2811-2.
23. Walker DH, Lesesne HR, Varma VA, Thacker WC. Rocky Mountain spotted fever mimicking acute cholecystitis. Arch Intern Med 1985; 145:2194-6.
24. Kirk JL, Fine DP, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine 1990; 69:35-45.
25. Sexton DJ, Corey GR. Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin Infect Dis 1992; 15:439-48.
26. Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999; 179: 1469-76.
27. Lochary ME, Lockhart PB, WilliamsWTJr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998; 17:429-31.